Other than targeting the PI3K/AKT/mTOR pathway, a recent study suggested that the inhibition of S6K1 and 4EBP1, its downstream effector proteins, helps control bladder tumor growth and progression [187]. The gene discussed is MTOR; the disease is urinary bladder neoplasm.